Charles River Laboratories (CRL) Tops Q4 EPS by 9c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops more than 4% on talks aimed at ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 359.41 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $359.41 | 52 Week High | $89.18 | |||
| Open | $359.41 | 52 Week Low | $65.70 | |||
| Day High | $359.41 | P/E | 167.17 | |||
| Day Low | $359.41 | EPS | $2.15 | |||
| Volume | 931 | |||||
